Verrica Receives Complete Response Letter from the FDA for its NDA for VP-102

Verrica has been advised that PAI (Pre-Approval Inspection) was conducted at Sterling and is not aware of any reported observations related to the PAI of VP-102 operations Review Division had advised Verrica that the review of NDA was completed...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news